Cleared Traditional

K850341 - CARDIOVASCULAR SET UP

K850341 is the FDA 510(k) clearance for CARDIOVASCULAR SET UP by Marwood Medical, Inc.. It is a Class 2 Cardiovascular device (product code DQO) cleared through the Traditional 510(k) pathway after a 28-day FDA review.

K850341 · Marwood Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1985
Decision
28d
Days
Class 2
Risk

K850341 is an FDA 510(k) clearance for the CARDIOVASCULAR SET UP. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by Marwood Medical, Inc. (Greensboro, US). The FDA issued a Cleared decision on February 25, 1985 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Marwood Medical, Inc. devices

Submission Details

510(k) Number K850341 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 28, 1985
Decision Date February 25, 1985
Days to Decision 28 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 125d · This submission: 28d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 295
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K850341.
DIAGNOSTIC INTRAVASCULAR CATHETERS
K853182 · Mallinckrodt Critical Care · Jan 1986
LAP-CATH
K852197 · Research Medical, Inc. · Nov 1985
FAP-CATH
K852456 · Research Medical, Inc. · Nov 1985
LARIAT CATHETER
K844598 · Mallinckrodt Critical Care · Feb 1985
PTCA GUIDING CATHER
K844161 · Cordis Corp. · Jan 1985
INTRAOPERATIVE ANGIOSCOPE DELIVERY CATH
K842798 · American Edwards Laboratories · Aug 1984